JENSEN BIOCONSULT ApS: Financial statements 2022
CVR: 35670491
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JENSEN BIOCONSULT ApS (CVR 35670491) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -5,440 and a net result of DKK -15,280 compared with DKK -14,480 the year before. Equity in the 2022 report amounted to DKK -1,102.
- Gross Profit
- DKK -5,440
- Profit/Loss
- DKK -15,280
- Equity
- DKK -1,102
- Total Assets
- DKK 234,396
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5 t. | -15 t. | -1 t. | - |
| 2021 | - | -6 t. | -14 t. | 14 t. | - |
| 2020 | - | -7 t. | -15 t. | 29 t. | - |
| 2019 | - | 6 t. | 5 t. | 43 t. | - |
| 2018 | - | 5 t. | 5 t. | 38 t. | - |
Official annual report
Keep an eye on JENSEN BIOCONSULT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JENSEN BIOCONSULT ApS has published its annual report for 2021. Gross profit came to DKK -5,630, and the net result was DKK -14,480.
About JENSEN BIOCONSULT ApS
JENSEN BIOCONSULT ApS is a Danish company of the type Anpartsselskab based in Stenløse, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named JENSEN BIOCONSULT IVS. The management consists of Simon Skjøde Jensen. The company is owned by Simon Skjøde Jensen. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -4,120 and a net result of DKK -32,288 compared with DKK -24,690 the year before. Equity in the 2025 report amounted to DKK -71,674.